ETC-159
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ETC-159, covering 2025-07-25 to 2025-07-25. Get the full timeline:
Most recent: Clinical Trial Update: ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers [Phase 1]